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SUMMARY 
The small GTPases of the Rho family are key intermediates in cellular signalling triggered by 
activated cell adhesion receptors. In this study, we took advantage of the siRNA technology to 
define the role of the best characterised members of the RhoGTPase family, RhoA, Rac1 and 
Cdc42 in the control of MMP-1, MMP-2 and type I collagen expression in normal human skin 
fibroblasts (HSF). A specific and long lasting repression, up to 7 day post-transfection, of the 
three GTPases was achieved by transient transfection of specific siRNA. The silencing of 
Cdc42, but not that of RhoA or Rac1, induced an increased MMP-1 secretion by 15-fold. This 
up-regulation was confirmed at the mRNA level and observed with 2 different siRNA 
targeting Cdc42. Such a regulation was also observed in various human cell lines and was 
rescued by reexpressing wild type Cdc42 encoded by a construct bearing silent mutations 
impeding its recognition by the siRNA. At the opposite, MMP-2 and type I collagen 
expression was not affected by the individual silencing of each RhoGTPase. Cytokine 
proteoarray, ELISA and RT-PCR measurements further revealed that ablation of Cdc42 
induced an overexpression of IL-8 and MCP-1. Although these cytokines are known to induce 
the expression of MMP-1, we proved that they were not involved in the Cdc42-mediated up-
regulation of MMP-1. Silencing of Cdc42 also induced an increased phosphorylation of 
ERK1,2 and p38 MAP kinase. The use of chemical inhibitors on Cdc42-ablated cells revealed 
that the up-regulation of MMP-1 is dependent on the ERK1,2 pathways while the p38 MAP 
kinase pathway displayed an inhibitory role. Using simultaneous knock-down of two or three 
RhoGTPases allowed to demonstrate that the RhoA-ROCK pathway was not involved in this 
regulation but the silencing of Rac1 reduced the effect of Cdc42 suppression. These data 
suggest that, in vivo, when the cell-ECM interactions via integrins induce cytoskeleton 
organisation, the MMP-1 expression is maintained at a low level by Cdc42 via a repression of 
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the Rac1 and ERK1,2 pathways. Therefore, Cdc42 contributes to ECM homeostasis and 
connective tissues integrity.  
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INTRODUCTION 
Interactions between cells and the ECM components are primarily mediated through receptors 
of the integrins family (Hynes, 1992). Engagement of integrin triggers the assembly of focal 
adhesions, induces the reorganisation of the cytoskeleton and the activation of various 
signalling cascades that culminate in the control of cell proliferation, survival, differentiation 
and gene expression (Danen et al., 1998). This includes the expression of genes coding for 
ECM components and for matrix metalloproteinases (MMPs), a family of zinc-dependent 
proteases that collectively degrade most components of the ECM and play a major role in 
physiological and pathological processes involving ECM remodelling. MMP-1, the founding 
member of this family of enzymes, is barely expressed in normal fibroblasts spread on a rigid 
support and is dramatically up-regulated by inhibition of the integrins functionality 
(Kheradmand et al., 1998) or by interfering with integrin-mediated cytoskeleton 
reorganisation either with cytochalasin D (Lambert et al., 1998; Unemori and Werb, 1986) or 
by culturing fibroblasts in freely retracting collagen gels (Mauch et al., 1989; Lambert et al., 
1992). Other MMPs like MMP-3, MMP-13 and the membrane bound MMP-14 (MT1-MMP), 
a MMP-2 activator, are similarly up-regulated, while type I and type III collagen expression is 
inversely controlled (Haas et al., 1998; Lambert et al., 2001a; Lambert et al., 2001b; Mauch et 
al., 1988).  
The small GTPases of the Rho family are at the cross-road of signalling pathways initiated by 
receptors to diffusible biological mediators as well as by clustered integrins. These are key 
signaling molecules regulating the architecture of the cytoskeleton (Hall, 1998) and the 
assembly of proteins into focal adhesions (Hotchin and Hall, 1995). Some of them have been 
implicated in the control of MMPs expression and activation. It was reported that Rac1 
activity was required for the induction of MMP-1 mediated by inactivation of the α5β1 
integrin (Kheradmand et al., 1998)  as well as for the type I collagen-dependent MMP-2 
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activation (Zhuge and Xu, 2001). It was also observed that constitutive activation of RhoA 
was sufficient to trigger MMP-1 expression in fibroblasts (Werner et al., 2001; Werner and 
Werb, 2002).  
The function of the RhoGTPases is difficult to assess in cells that are refractory to 
transfection. Moreover, bacterial toxins but also mutated Rho-proteins are not fully specific 
for one RhoGTPase (Lerm et al., 2000; Ridley, 2001). In this report, we used the siRNA 
technology (Elbashir et al., 2001) to analyze the role of the best characterised members of the 
RhoGTPase family, RhoA, Rac1 and Cdc42 in the control of MMP-1, MMP-2 and type I 
collagen expression in normal human skin fibroblasts (HSF) cultured on a rigid substrate. The 
silencing of Cdc42, but not RhoA nor Rac1, in HSF induces a significant overexpression of 
MMP-1 at both the mRNA and the protein level while the expression of MMP-2 and type I 
collagen is not affected. Multiple knockdown experiments and the use of chemical inhibitors 
demonstrate that the up-regulation of MMP-1 is dependent on the Rac1 and ERK1,2 
pathways, while the RhoA-ROCK pathway was not involved and the p38 MAP kinase 
pathway displays an inhibitory role. 
 
MATERIALS AND METHODS 
Reagents and cells 
Y-27632 was kindly supplied by A. Yoshimura (Welfide Co, Japan). PP2 and U0126 were 
from Calbiochem,  Herbimycin A and LY294 from Sigma and SB203580 from Alexis 
corporation. Antibodies were purchased from the following manufacturers: mouse anti-RhoA 
(#sc-418), mouse anti-Stat1α (#sc-417), rabbit anti-myosin regulatory light chain (#sc-15370) 
and goat anti-phospho-myosin regulatory light chain (#sc-12896) from Santa Cruz 
Biotechnology; mouse anti-Rac1 (23A8) from Upstate Biotechnology; mouse anti-Cdc42 
from BD Biosciences; rabbit anti-ERK-1,2 (M-5670) and mouse monoclonal anti-phospho-
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ERK1,2 (M-8159) from Sigma, mouse monoclonal anti-human p38 (AHO0782) and rabbit 
polyclonal anti-phospho-p38 (44-684Z) were from BioSource International, mouse anti-
human MMP-1 (Mab3307) from Chemicon, mouse blocking anti-human MCP-1 (Mab279) 
and anti-human IL-8 (Mab208) from R&D Systems. The blocking antibodies concentration 
used were 10 times higher than the one required to inhibit either the migration of monocytes 
induced by 20ng/ml rhMCP-1 or the migration of neutrophiles induced by 20ng/ml rhIL-8. 
Human primary skin fibroblasts (HSF) were isolated by the explant procedure from normal 
human dermis and amplified in Dulbecco’s modified Eagle’s medium (Invitrogen) 
supplemented with 10% FCS (Cambrex). Cells were trypsinized 1:3 every week and used 
between passages 8 and 13. Human breast adenocarcinoma cell line HS578T, human 
fibrosarcoma cell line HT1080 and human melanoma cell line A2058 were amplified in 
Dulbecco’s modified Eagle’s medium supplemented with 8% FCS and trypsinized 1:10 every 
week. When indicated, cells were starved by serum deprivation for 16h. 
 
siRNA transfection 
21-nucleotides long siRNAs were chemically synthesized, desalted, deprotected and PAGE 
purified (Eurogentec). The 5’-GAAGUCAAGCAUUUCUGU-CTT-3’ and 5’-
GACAGAAAUGCUUGACUUCTT-3’ oligoribonucleotides were used to inhibit RhoA 
synthesis; the 5’-CACCACUGUCCCAACACUCTT-3’ and 5’-
GAGUGUUGGGACAGUGGUGTT-3’ oligoribonucleotides were used to inhibit Rac1 and 
the 5’-GAUAACUCACCACUGUCCATT-3’ and 5’-UGGACAGUGGUGAGUUAUCTT-3’ 
oligoribonucleotides (1st siCdc42) or the 5’-GACUCCUUUCUUGCUUGUUTT-3’ and 5’-
AACAAGCAAGAAAGGAGUCTT-3’ oligoribonucleotides (2nd siCdc42) were used to 
inhibit Cdc42. As a control we used  a  randomly mixed sequences of the 1st siCdc42 5’-
AUACUUACGCACGCUCCAATT-3’ and 5’-UUGGAGCGUGCGUAAGUAUTT-3’ 
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oligoribonucleotides. Each pair of oligoribonucleotides was annealed at a concentration of 20 
µM in 50 mM NaCl, 1mM EDTA, 10 mM Tris-HCl pH 7.5. In some experiments, the two 
siRNA targeting Cdc42 and the control siRNA were transcribed in vitro with the SilencerTM 
siRNA Construction Kit from Ambion (#1620). Calcium phosphate-mediated transfection 
was performed overnight (14-16 hours) on subconfluent cells at a final concentration of 
siRNA ranging from 0.6 nM to 60 nM. Cells were washed twice with PBS and once with 
complete medium, this last step was defined as time 0 post-transfection. At 24h post-
transfection, each pool of transfected cells was trypsinized and seeded at sub-confluence in 6 
well-plates. In each experiment, a series of wells was dedicated to the evaluation of the 
silencing of the RhoGTPases by Western blotting analysis.  
 
Immunoblotting and Zymography 
Sub-confluent HSF were rinsed twice with and scraped in ice-cold PBS. One third of the cell 
suspension was used to measure the DNA content by a fluorimetric technique and the 
remaining was lysed in SDS-PAGE lysis buffer. Samples equivalent to 0.5µg DNA were 
separated on a 15% gel under reducing conditions. To analyse MMP-1 expression, serum free 
medium was conditioned by sub-confluent transfected fibroblasts at the indicated post-
transfection time. Media conditioned by a number of fibroblasts equivalent to 0.5µg DNA 
were separated on a 10% gel under reducing conditions. Proteins were transferred to 
Immobilon-P PVDF membranes  and immunodetected with the corresponding antibodies. The 
bands were visualised with the ECL system (Amrsham). To determine MMP-2 secretion, 
aliquots of conditioned media corresponding to 0.05 µg DNA were subjected to zymography 
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GTPase assays 
The assay was carried out as previously described (Deroanne et al., 2003). Briefly, cells were 
chilled on ice and lysed in ice-cold buffer containing 1% Triton X-100, 25 mM HEPES pH 
7.3, 150 mM NaCl, 4% glycerol, 0.1 mM PMSF, 4 µg/ml aprotinin, 1 µg/ml leupeptin and 
1µg/ml pepstatin. Lysates were centrifuged for 8 min. at 13000g. Supernatants were 
immediately frozen in liquid nitrogen and stored at –80° until used. An aliquot of each 
supernatant was denatured in SDS-PAGE lysis buffer before freezing to measure the total 
RhoGTPase content by Western blotting. For pull-down assays, supernatants were incubated 
for 30 min with 30 µg of GST-PBD protein containing the Cdc42 and Rac binding region of 
PAK-1B, or GST-RBD protein containing the Rho binding region of rhotekin affinity linked 
to glutathione-Sepharose beads (Ren et al., 1999; Sander et al., 1999). The beads were washed 
4 times in lysis buffer and boiled in 60µl SDS-PAGE lysis buffer. 
 
RT-PCR analysis 
The RT-PCR amplifications were performed in an automated thermocycler (GeneAmp PCR 
system 9600) using a GeneAmp Thermostable rTth Reverse Transcriptase RNA PCR kit, 
Perkin Elmer) with pairs of primers amplifying mRNA coding for human MMP-1 (5’-
GAGCAAACACATCTGAGGTACAGGA-3’ and 5’-
TTGTCCCGATGATCTCCCCTGACA-3’), human MMP-2 (5’-
AGATCTTCTTCTTCAAGGACCGGTT-3’ and 5’-GGCTGGTCAGTGGCTTGGGGTA-
3’), human α1I collagen (5’-CCCACCAATCACCTGCGTACAGA-3’ and 5’-
TTCTTGGTCGGTGGGTGACTCTGA-3’), human Stat-1 (5’-
CGCACACAAAAGTGATGAACATGGA-3’ and 5’-
GGCTGACGTTGGAGATCACCACA-3’), human MCP-1 (5’-TAGCAGCCACCTTCATT-
CCCCAAG-3’ and 5’-AATGGTCTTGAAGATCACAGCTTC-3’), human IL-8 (5’-
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GCCAAGGAGTGCTAAAGAACTTAG-3’ and 5’-GAATTCTCAGCCCTCTTCAAAAAC-
3’), human COX-2 (5’-AGAACTTGCATTGATGGTGACTGTTT-3’ and 5’-
TTCTCCTTGAAAGGACTTATGGGTAA-3’), human Cdc42 (5’-
GCCCGTGACCTGAAGGCTGTCA-3’ and 5’-TGCTTTTAGTATGATGCCGACACCA-
3’), mCdc42 (5’-GCCCGTGACCTGAAGGCTGTCA-3’ and 5’-
CAGTCGAGGCTGATCAGCGGTTTA-3’) and 28S rRNA (5’-
GTTCACCCACTAATAGGGAACGTGA-3’ and 5’-
GGATTCTGACTTAGAGGCGTTCAGT-3’).  For MMP-1, MMP-2, α1I  and the 28S rRNA, 
the efficiency of the RT-PCR was controlled by a synthetic RNA co-transcribed and co-
amplified with the same primers as the endogenous RNA to yield an amplification product of 
larger size (Lambert et al., 2001a; Lambert et al., 2001b). For human Stat-1, MCP-1,  IL-8, 
COX-2, Cdc42 and mCdc42, the length of the RT-PCR product was of 234, 171, 222, 282, 
195 and 205-bp, respectively. For quantitative RT-PCR measurements, 10 ng of total RNA 
and a known copy number of the standard synthetic RNA for MMP-1, MMP-2, α1I  or 28S 
rRNA were used per 25 µl reaction mixture (final volume). The RT step (70°C for 15 min) 
was followed by a 2-min incubation at 94°C, for denaturation of RNA-DNA heteroduplexes, 
and then by amplification for 24 cycles (MMP-1), 25 cycles (MMP-2), 23 cycles (α1I ), 18 
cycles (28S rRNA), 30 cycles (Stat1, MCP-1 and IL-8) or 23 cycles (Cdc42 and mCdc42). 
The PCR conditions were 94°C for 15 s, 66°C for 20 s and 72°C for 10 s. The RT-PCR 
products were quantified after electrophoresis on a 10% polyacrylamide gel and staining 
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ELISA and cytokine proteoarray 
The expression of cytokines was measured in serum-free medium conditioned between day 2 
and 3 post-transfection. A first screening of 79 cytokines was achieved with RayBioTM 
Human Cytokine Array Map V (RayBiotech, Inc.; #H0108005)  following manufacturer’s 
instructions. The expression levels of IL-8, MCP-1 and interferon-β were also analysed with 
ELISA kits from R&D Systems (#D8000C, #DCP00 and #41400-1) following manufacturer’s 
instructions.  
 
Rescue of Cdc42 knock-down 
The entire coding sequence of Cdc42 was amplified by RT-PCR. The amplification product 
was mutated by mean of a PCR-based approach with mutated primers. Six silent mutations 
were introduced in the sequence targeted by the 1st siCdc42 in order to make it resistant to this 
siRNA. The mutated Cdc42 cDNA (mCdc42) was cloned into pShuttle (CLONTECH 
Laboratories, Inc.). Sequencing confirmed that the 6 expected mutations were introduced into 
the cDNA. Rescue experiments were carried out with HS578T cells cultured in 6 well plates.  
The cells were  seeded at a density of 1.5x105 cells per well. Eight hours after seeding, they 
were transfected with 20nM of siScr or 20nM of siCdc42 for 14-16h following the protocol 
described above. Immediately after the washing step, 1µg of empty pShuttle or 1µg of 
pShuttle-mCdc42 was transfected into cells for 20-24h with 3µl of Genejuicetm  (Novagen) 
following the manufacturer protocol. Each pool of transfected cells was trypsinized and 
seeded at sub-confluence in 6 well-plates. In each experiment, a series of wells was dedicated 
to the evaluation of the expression level of Cdc42 and MMP-1 by Western blotting analysis 
and another series to evaluate the expression level of both endogenous and  mutated Cdc42 
mRNA by RT-PCR.  
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RESULTS 
Specific inhibition of RhoA, Rac1 and Cdc42 expression by siRNA. 
The RhoA-targeting siRNA designed in a previous work (Deroanne et al., 2003) served as a 
guideline to define the siRNA target sequences for Rac1 and Cdc42 which were chosen in the 
same region of the mRNA sequence. As a control, an irrelevant siRNA (siScr), i.e. a 
randomly mixed sequence of the 1st siRNA targeting Cdc42 was used. Human skin fibroblasts 
(HSF) were transiently transfected with either 20nM of the respective specific or control 
siRNA or treated with calcium phosphate alone. As shown in Figure 1A, Western blot 
analysis of whole cell lysates three days post-transfection revealed a more than 90% reduction 
in the RhoA and Cdc42 protein level and an 80% reduction in the Rac1 protein level without 
any significant modulation of the amount of ERK1,2 used as control. The irrelevant siRNA 
had no effect on any of these proteins. The specific inactivation of the RhoA, Rac1 and Cdc42 
pathways was confirmed by pull-down assays which revealed a similar repression of their 
GTP-bound forms (not shown). Interestingly, the silencing of one RhoGTPase did not alter 
neither the expression level nor the activation level of the others. Repression of Cdc42 by 
more than 80% of the control was maintained  for up to 7 days (Fig.1B), while Rac1 and 
RhoA were inhibited respectively for 5 and 9 days (not shown). As observed by phase-
contrast microscopy, ablation of RhoA did not induce significant morphological alterations 
while that of Rac1 decreased lamellipodia formation and ablation of Cdc42 induced a more 
“dendritic” morphology (Fig.2).  
 
The silencing of Cdc42 up-regulates the expression of MMP-1. 
In HSF spread on a rigid support, the expression of MMP-1 is low as compared to 
experimental conditions where the actin cytoskeleton is disrupted by cytochalasin D (Lambert 
 11
MMP-1 regulation by Cdc42 
et al., 1998, Unemori and Werb, 1986) or by culturing cells in a freely retracting collagen gel 
(Lambert et al., 1992; Langholz et al., 1995; Mauch et al., 1989). In HSF cultured in 
monolayer the silencing of Cdc42 induced a 15 fold increased MMP-1 secretion, as measured 
by Western blot analysis of conditioned media. By contrast, the expression of MMP-1 was not 
affected by RhoA or Rac1 silencing (Fig.3A and 3B). The induction of MMP-1 was already 
detectable at a concentration of 2nM of siRNA and reached a maximum at 6nM and then 
leveled off up to 60nM of siRNA (Fig.3C). The induction of MMP-1 expression by silencing 
Cdc42 was confirmed at the mRNA level by RT-PCR analysis  (Fig.4A-B). By contrast, the 
expression of α1I collagen and MMP-2 was not affected by the silencing of the RhoGTPases 
(Fig. 4A-B). Analysis of serum-free mediums conditioned by the transfected HSF for 
gelatinase activity by zymography revealed that an equivalent level of the latent form of 
MMP-2 was present in all tested conditions while the active forms were not detected (not 
shown).  None of the siRNA induced a significant overexpression of the signal transducer and 
activator of transcription 1, Stat1 (Fig. 4C). On the contrary, the Rac1 siRNA significantly 
repressed the Stat1 steady-state level. Moreover, interferon-β expression was below the 
detection limit of our ELISA kit (not shown). This suggests that the phenotypic modulations 
induced by the siRNA are not related to the activation of the interferon system as recently 
reported in other models (Sledz et al., 2003). A second siRNA targeting another sequence of 
Cdc42 repressed Cdc42 as efficiently as the previous one and induced a similar 
overexpression of MMP-1 at both the mRNA and protein levels (Fig. 5).  
 
The MMP-1 overexpression induced by silencing Cdc42 requires Rac1 
It has been reported in various models that a transient activation of either RhoA or Rac1 is a 
necessary step in the signal transduction cascade leading to MMP-1 production (Kheradmand 
et al., 1998; Werner et al., 2001). To address their role in the induction of MMP-1 following 
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Cdc42 silencing, we performed  a simultaneous repression of two or the three RhoGTPases by 
cotransfection of two or three siRNA. In these experiments, each RhoGTPase-targeting 
siRNA was used at a final concentration of 10 nM. The siScr was added to the transfection 
mix to reach a final concentration of 30 nM when only one or two specific siRNA were used. 
Western blot analysis of whole cell lysates collected three days post-transfection confirmed 
the striking specificity of the repression of each RhoGTPase and revealed a lack of significant 
interference between the individual silencing after cotransfection with the siRNA targeting the 
other RhoGTPases (Fig.6). Western blot analysis of media conditioned by the transfected 
fibroblasts confirmed that only the silencing of Cdc42 induces MMP-1 expression. The co-
silencing of Rac1 and Cdc42, but not that of RhoA and Cdc42, significantly reduced the 
MMP-1 overexpression suggesting that Rac1 participate in the up-regulation of MMP-1 
following Cdc42 silencing. The ROCK inhibitor Y27632 used at 10 µM, a concentration 
inhibiting more than 80% of Myosin regulatory Light Chain phosphorylation, did not 
antagonise the MMP-1 overexpression induced by silencing Cdc42 (not shown) further 
suggesting that the RhoA-ROCK pathway is not involved in the process analysed here. It 
should be noted that Y27632 did not affect Cdc42 silencing (not shown). 
 
The silencing of Cdc42 up-regulates IL-8 and MCP-1 expression. 
To analyse the expression profile of cytokines by siCdc42 transfected HSF, proteoarrays were 
used to evaluate the concentration of 79 different cytokines in the conditioned media. They 
revealed an overexpression of IL-8, IL-6 and MCP-1 by HSF transfected with the siRNA 
Cdc42 (Fig. 7A). The up-regulation of IL-8 and MCP-1, two cytokines known to induce 
MMP-1, was confirmed by RT-PCR and ELISA (Fig. 7B and 7C). It should be noted that IL-
1α and IL-1β mRNA were barely detectable in transfected HSF and neither IL-1α nor IL-1β 
was detected by proteoarray analysis or by ELISA (not shown). The involvement of IL-8 and 
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MCP-1 in the control of MMP-1 expression by Cdc42 was assessed by using blocking 
antibodies. Treatment of transfected HSF with up to 10µg/ml of blocking anti-IL-8 or anti-
MCP-1 antibodies did not alter the induction of MMP-1 following silencing of Cdc42 (not 
shown). This suggests that MMP-1 overexpression occurs independently of that of IL-8 or 
MCP-1. 
 
The induction of MMP-1 following Cdc42 silencing is mediated through the ERK1,2 pathway. 
We noted that in starved HSF the electrophoretic pattern of ERK1,2 was modified following 
Cdc42 silencing, suggesting a shift as observed when these proteins are phosphorylated.  The 
analysis of the phosphorylation status of ERK1,2 and p38 with phospho-specific antibodies 
revealed that ablation of Cdc42 induced an activation of both ERK1,2 and p38 as compared to 
HSF transfected with other siRNAs (Fig. 8A). The role of the ERK1,2, the p38 MAP kinase 
and PI3Kinase pathways in the intracellular signaling mediating the MMP-1 overexpression 
in Cdc42-ablated cells was evaluated by pharmacological inhibition. Transfected HSF were 
treated with U0126, a specific MEK1,2 inhibitor, and SB203580, a specific p38 MAP kinase 
inhibitor. The overexpression of MMP-1 following Cdc42 silencing was significantly 
decreased with a concentration of U0126 as low as 1µM. Similar results were observed in 
HSF transfected with the second siRNA targeting Cdc42 (Fig. 9). On the contrary, inhibition 
of the p38 MAP kinase with SB203580 concentrations ranging from 2 to 6 µM significantly 
increased the MMP-1 expression (Fig. 8) while barely affecting it at concentrations ranging 
from 0.01 to 0.3 µM (Fig.9). These observations confirm the involvement of the ERK1,2 
pathway in the overexpression of MMP-1 following ablation of Cdc42. The contribution of 
the PI3K and src signalling pathways was similarly investigated. The PI3K inhibitor LY294 
did not affect MMP-1 expression in siCdc42 transfected HSF (Fig.8). The tyrosine kinase 
inhibitor Herbimycin A, used at 260 nM, completely suppressed the induction of  MMP-1, 
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while a more specific src-kinase inhibitor PP2 (1 µM) was inactive (not shown). It should be 
noted that these inhibitors did not modify the silencing of Cdc42 (illustrated for U0126, 
SB203580 and LY294 in fig. 8 and 9).  
 
The induction of MMP-1 following Cdc42 is observed in human cell lines from various origin. 
To extend the significance of our results, the control of MMP-1 expression by Cdc42 was also 
tested in human cell lines from various origin. Human breast adenocarcinoma cell HS578T, 
human fibrosarcoma cells HT1080 and human melanoma cells A2058 were transfected with 
either the irrelevant siRNA (siScr) or the first siRNA targeting Cdc42 (siCdc42). Western blot 
analysis of whole cell lysates 72h post-transfection revealed a significant silencing of Cdc42 
by siCdc42. Western blot analysis of the corresponding conditioned media demonstrated a 
significant overexpression of MMP-1 following Cdc42 in the three cell lines (Fig.10) 
suggesting that this mechanism of regulation is not limited to HSF.  
 
The rescue of Cdc42 silencing repressed MMP-1 overexpression 
To confirm the role of Cdc42 in this control of MMP-1, the silencing of Cdc42 was rescued 
by expressing a Cdc42 mRNA made resistant to the siRNA by 6 silent mutations and coding 
for a wild-type Cdc42 protein (mCdc42). While each cell lines was easily transfected with the 
siRNA, preliminary analysis revealed that HS578T are by far the most efficiently transfected 
cells with an expression vector for the Enhanced Green Fluorescent Protein (not shown). 
Rescue experiments were therefore carried out with this cell type. HS578T seeded in 6 well 
plates were first transfected overnight with 20nM of either siScr or siCdc42. Then, the cells 
were washed and immediately transfected with 1µg of empty pShuttle or 1µg of pShuttle-
mCdc42 for 20-24h. The specific measurement of the mCdc42 mRNA was achieved by RT-
PCR using a primer complementary to a nucleotide sequence of pShuttle localised between  
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the multiple cloning site and the polyadenylation site, i.e. in the 3’UTR specific of mCdc42 
mRNA. The lack of amplification product when the RT step was omitted demonstrated that 
only mCdc42 mRNA was amplified (Fig. 11, top left panel). RT-PCR analysis of total RNA 
extracted from HS578T 72h post-transfection demonstrated that (i) the silencing of the 
endogenous Cdc42 mRNA by the  siCdc42 was as efficient after transfection of either the 
empty pShuttle or the pShuttle-mCdc42, (ii) the mutated Cdc42 mRNA was not ablated by the 
siCdc42 (Fig. 11).  Western blot analysis of whole cell lysates and of the conditioned medium 
of HS578T demonstrated that the reexpression of Cdc42 by transfecting pShuttle-mCdc42 
after transfection of siCdc42 significantly decreased the expression of MMP-1 (Fig.11). These 




Interactions of cells with their support are primarily mediated by the heterodimeric receptors 
of the integrin family (Hynes, 1992). These receptors are thought to play a key role in the 
control of cell behavior by the ECM, in part through their ability to drive cytoskeleton 
organization which influences the pattern of gene expression (Danen et al., 1998). There is 
extensive evidence that integrins control actin polymerisation via members of the Rho family 
of  small GTPases (Juliano et al., 2002). Among them, RhoA, Rac1 and Cdc42 are the best 
characterised and elicit distinct effects on actin structures. RhoA regulates the formation of 
the actin stress fibres through bundling of pre-existing filaments, while Rac1 and Cdc42 are 
required for the formation of lamellipodia and filopodia, respectively, via de novo actin 
polymerisation (Hall, 1998). In fibroblasts, the expression of MMP-1 is tightly controlled by 
integrin-mediated interactions with ECM components. Fibroblasts spread on a rigid substrate, 
express low levels of MMP-1. Inhibiting integrin function by mean of blocking antibodies 
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(Kheradmand et al., 1998) or interfering with integrin-mediated cytoskeleton organisation 
with cytochalasin D or by culturing cells in floating collagen gels dramatically increases 
MMPs expression (Mauch et al., 1989; Lambert et al., 1992; Lambert et al., 2001b). We 
hypothesised that the low expression level of MMP-1 in fibroblasts spread on a rigid substrate 
involves small GTPases of the Rho family. The conventional methods to target the 
RhoGTPase pathways include the mutated forms of the Rho proteins (Feig, 1999), the p21-
binding domain of their effectors (Nur-E-Kamal et al., 1999) and a class of bacterial toxins 
that modulate their activity (Lerm et al., 2000). Although widely used, each of these 
approaches has its own drawbacks. Dominant negative forms could be less specific than 
expected as some GEFs are shared by several RhoGTPases. Moreover, overexpression of 
mutated proteins is precluded in cells that are refractory to transfection and may not be 
adequate to many experimental situations. Similarly, the limited specificity of bacterial toxins 
did not allow differential analysis of highly homologous Rho proteins. In this report, we took 
advantage of the siRNA technology to investigate the role of RhoA, Rac1 and Cdc42, in the 
control of the expression of MMP-1, MMP-2 and type I collagen. This experimental approach 
proved especially suited for these investigations in the hard-to-transfect primary human skin 
fibroblasts. It proved very efficient and specific in silencing each GTPase without significant 
alteration of the overall protein synthesis as suggested by the constant steady-state level of 
ERK1,2 used as control. It is well-established that activated GTPases translocated to the cell 
membrane where they bind and activate their downstream effectors (del Pozo et al., 2000). In 
this cell compartment, the GTPases could have a half-life different from that of the 
cytoplasmic inactive GDP-bound form. The repression of both the active and inactive forms 
was confirmed with a pull-down assay and definitively validated the siRNA approach. This 
targeting was very specific and, further, we did not observe any compensatory modulation of 
the steady-state level or activation level of one GTPase due to the silencing of another 
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GTPase was observed. These results are in agreement with recent observations in Rac1-
deficient macrophage (Wells et al., 2004).  
Recently, Sledz et al. (2003) reported the activation of the interferon system and observed a 
strong up-regulation of Stat1 upon siRNA transfection in T98G cells. In our system, this side-
effect did not occur since the Stat1 protein level was not increased upon transfection with 
20nM of siRNAs. Moreover, the expression level of interferon-β was below the detection 
limit of the ELISA kit used here (not shown). These results suggest that the interferon system 
is not activated in HSF following siRNA transfection. This discrepancy could be related to the 
type of cell used and/or to the transfection method, calcium phosphate precipitation in our 
study versus “OligofectamineTM” in the study of Sledz et al. (2003). The repression of Stat1 
by the Rac1 siRNA as we observed here would be worthwhile to further investigate in another 
context. 
Titration of the siRNA targeting Cdc42 revealed that the induction of MMP-1 is observed at 
concentrations as low as 2 nM, reached a plateau around 6 nM and did not further increase up 
to 60 nM demonstrating that this effect is saturable. The use of a second siRNA targeting 
another sequence of Cdc42 confirmed the role of Cdc42 in the control of MMP-1 expression. 
Silencing of Cdc42 induced a significant increase of MMP-1 expression in human cell lines 
from various origin suggesting that the negative regulation of MMP-1 by Cdc42 is a 
widespread mechanism. In HS578T cells, the effect of Cdc42 silencing was rescued by 
reexpressing wild type Cdc42. The residual expression of MMP-1 upon rescue of Cdc42 
silencing is likely due to the 10 to 30% of cells which has not been transfected by pShuttle-
mCdc42. These data definitively confirmed the involvement of Cdc42 in the control of MMP-
1 expression. 
The exquisite flexibility of the siRNA technology allowed to simultaneously knock-down the 
three RhoGTPases with a specificity that cannot be reached by any other methods currently 
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used. By mean of multiple knock-down experiments, a role for Rac1 but not RhoA in MMP-1 
overexpression following Cdc42 silencing was demonstrated. These results highlight an 
antagonistic effect of Cdc42 and Rac1 on MMP-1 expression. As Rac1 activity does not seem 
to be affected by the silencing of Cdc42, we hypothesise that pathway(s) downstream of Rac1 
is (are) targeted by Cdc42. WASP and WAVE family proteins are potential candidates as they 
are common intracellular signalling effectors of the Cdc42 and Rac1 pathways involved in the 
regulation of the actin dynamics (Takenawa and Miki, 2001). The participation of Rac1 in the 
overexpression of MMP-1 is in agreement with previous report demonstrating the requirement 
for Rac1 activity in MMP-1 overexpression mediated by anti-integrin blocking antibodies 
(Kheradmand et al., 1998). Rac1 is the most “resistant” GTPase to siRNA ablation. It could 
not be repressed lower than 20-30% of its original steady-state level in our HSF. This might 
explain why co-silencing of Cdc42 and Rac1 did not result in a complete suppression of 
MMP-1 overexpression. Finally, the lack of inhibition of MMP-1 expression by the ROCK 
inhibitor, Y-27362, definitively ruled out the involvement of the RhoA-ROCK pathway in the 
MMP-1 up-regulation following Cdc42 silencing (not shown).  
In fibroblasts, it was reported that IL-1α and IL-1β are “signalling intermediates” acting 
through autocrine loops to mediate MMP-1 up-regulation triggered either by cytoskeleton 
disorganisation (West-Mays et al., 1995), phagocytosis (Werner et al., 2001), integrin 
inactivation (Kheradmand et al., 1998) or interaction with specific ECM components (Utani et 
al., 2003). However, these cytokines were undetectable at the protein level and barely 
detectable at the mRNA level in transfected HSF, excluding their involvement in the process 
studied in this report. The expression profile of cytokines in transfected HSF was further 
analysed by using proteoarrays. Among the 79 cytokines tested, only MCP-1 and IL-8 were 
modulated by the silencing of Cdc42. Although these cytokines are potential inducers of 
MMP-1 expression in HSF (Yamamoto et al., 2000), they were not involved in our 
 19
MMP-1 regulation by Cdc42 
experimental conditions as suggested by the lack of effect of anti-MCP-1 and anti-IL-8 
blocking antibodies. As MMPs and prostaglandins levels often parallel each other, the COX-2 
mRNA level was also analysed by RT-PCR (not shown). However, the lack of induction of 
COX-2 mRNA following Cdc42 silencing suggest that the prostaglandins synthesis was not 
affected. 
Our results point to an involvement of ERK1,2 in the overexpression of MMP-1 following 
Cdc42 silencing while the p38 MAP kinase pathway plays an inhibitory role, as suggested by 
the increased expression of MMP-1 in fibroblasts treated with the p38 MAP kinase inhibitor 
(Fig. 8), most likely by inhibiting the activation of ERK1,2 (data not shown). SB203580 has 
been shown to inhibit MMP-1 expression at low concentrations (Xu et al., 2001). However, in 
our model, concentrations of SB203580 ranging from 0.01 to 0.3 µM barely affected the 
MMP-1 expression suggesting that the p38 pathway did not play a key role in the regulation 
studied here. Several reports point to the divergent regulation of MMPs by the ERK1,2 and 
the p38 pathways (Ridley et al., 1997; Brauchle et al., 2000; Reunanen et al., 2002). 
Interestingly, Rac1 and Cdc42 were reported to control p38 MAP kinase activation (Minden 
et al., 1995) a process responsible for the inhibition of both ERK1,2 activation and MMP-1 
expression (Singh et al., 1999; Westermarck et al., 2001), while a specific inhibitor of the p38 
MAP Kinase pathway is known to activate the ERK1,2 pathway (Aguirre-ghiso et al., 2003). 
Moreover, the inhibition of the Rac1 and Cdc42 pathways resulted in ERK1,2 activation 
(Zugasti et al., 2001). The PI3Kinase and src-kinase pathways are also potentially involved in 
the regulation of MMPs in fibroblasts (Vincenti et al., 1996; Liao et al., 2003). However, their 
specific inhibition did not affect MMP-1 expression in our model.  
In fibroblasts, an antagonistic regulation of MMP-1 and type I collagen is usually observed by 
modulating cell-ECM interactions or integrin-mediated cytoskeleton organisation (Lambert et 
al., 1992; Lambert et al., 1998). However, in three-dimensional collagen gel, the signalling 
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pathways modulating the expression of these genes are not coupled (Langholz et al., 1995). 
This is also the case in our model where the type I collagen expression was not regulated 
following Cdc42 silencing suggesting that Cdc42 do not exert a general control on the 
integrins-regulated genes.  
In summary, our study is an additional evidence of the extreme power of the siRNA 
technology to analyse RhoGTPases functions. This approach enabled us to underscore the key 
role played by Cdc42 in the control of the expression of MMP-1, one main enzyme involved 
in the degradation of the most abundant ECM protein, type I collagen. Our data suggest that, 
in vivo, when integrins-mediated interactions between cells and ECM  induce a cytoskeleton 
organisation, MMP-1 expression is maintained at a low level by Cdc42 via a repression of the 
Rac1 and ERK1/2 pathways.  The differential regulation of MMP-1 and type I collagen could 
play a key role in ECM homeostasis and connective tissue remodelling as well as in the 
control of the mechanochemical information delivered to the cells by the ECM which governs 
the differentiation state of various cell types (Deroanne et al., 2001; Ingber, 2002). A 
deregulation of this function of Cdc42 could be at the origin of pathologies associated to 
excessive matrix degradation such as arthritis, ulcers, atherosclerosis, aneurysms but also 
tumor progression as it was recently reported that MMP-1 overexpression in invasive 
melanoma cells is mediated by the ERK1,2 pathway (Huntington et al., 2004). 
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Fig. 1. Specific silencing of RhoA, Rac1 and Cdc42 mediated by  transient transfection 
of siRNA.  (A) Western blot analysis of whole cell lysates of HSF transfected with calcium 
phosphate alone (CaP), with 20 nM of the siRNA targeting RhoA (siRhoA), Rac1 (siRac1) or 
Cdc42 (siCdc42), or with 20 nM of an irrelevant siRNA (siScr). 72 hours post-transfection, 
the cells were lysed in SDS-PAGE loading buffer and analyzed by immunoblotting with 
specific antibodies to RhoA, Rac1, Cdc42 and ERK1,2. (B) Western blot analysis of whole 
cell lysates of HSF transfected with 20 nM of an irrelevant siRNA (siScr) or with 20 nM of 
the siRNA targeting Cdc42 (siCdc42). Cells were lysed in SDS-PAGE loading buffer between 
day 1 and day 9 post-transfection and analysed by immunoblotting with specific antibodies to 
Cdc42 and ERK1,2.  
 
Fig. 2. Morphological effects of RhoA, Rac1 or Cdc42 silencing in human skin 
fibroblasts.  Representative phase-contrast microscopy of HSF 72h post-transfection with  
calcium phosphate alone (CaP), 20 nM of an irrelevant siRNA (siScr) or with 20 nM of the 
siRNA targeting RhoA (siRhoA), Rac1 (siRac1) or Cdc42 (siCdc42). Bar, 20µM. 
 
Fig. 3. Cdc42 silencing up-regulates MMP-1 protein level. 
(A) Representative Western blot analysis of serum-free media conditioned by HSF for 16h 
between day 2 and day 3 post-transfection with calcium phosphate alone (CaP),  with 20 nM 
of an siRNA targeting RhoA (siRhoA), Rac1 (siRac1) or Cdc42 (siCdc42), or with 20 nM of 
an irrelevant siRNA (siScr). (B) Densitometric analysis of (A). Results are the mean+s.d. of 
three independent experiments. (C) Representative Western blot analysis of cell lysates of 
HSF 72h post-transfection (cell lysates) or serum free media conditioned by HSF for 16h 
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between day 2 and day 3 post-transfection (C.M.). Cells were transfected with the indicated 
concentrations of either an irrelevant siRNA (siScr) or the siRNA targeting Cdc42 (siCdc42). 
 
Fig. 4. Cdc42 silencing up-regulates MMP-1 but not MMP-2 nor α1I mRNA steady-state 
level. 
(A) Representative quantitative RT-PCR analysis of MMP-1, MMP-2 and α1I mRNA level 
and 28S rRNA in total RNA extracted from HSF cultured in DMEM+10%FCS 72h post-
transfection with calcium phosphate alone (CaP), an irrelevant siRNA (siScr) or with the 
siRNA targeting RhoA (siRhoA), Rac1 (siRac1) or Cdc42 (siCdc42). Sample to sample 
variations in RT-PCR efficiency is controlled by adding a known copy number of synthetic 
RNA co-transcribed and co-amplified with the same primers which generate a product of 
larger size (*). (B) Densitometric analysis of (A). Results are the mean+s.d. of three 
independent experiments. (C) Western blot analysis of whole cell lysates of HSF transfected 
with calcium phosphate alone (CaP), with 20 nM of the siRNA targeting RhoA (siRhoA), 
Rac1 (siRac1) or Cdc42 (siCdc42), or with 20 nM of an irrelevant siRNA (siScr). 72 hours 
post-transfection, the cells were lysed in SDS-PAGE loading buffer and analysed by 
immunoblotting with specific antibodies to Stat1α and ERK1,2. 
 
Fig. 5. A second siRNA targeting another region of the Cdc42 mRNA also up-regulates 
MMP-1.  Representative Western blot analysis of  whole cell lysates  and of serum free media 
conditioned by HSF 72h post-transfection with 20 nM of  an irrelevant siRNA (siScr), the 
first siRNA targeting Cdc42 (1st siCdc42) or the second siRNA targeting Cdc42 (2d siCdc42) 
with specific antibodies to Cdc42, ERK1,2 and MMP-1;  RT-PCR analysis of MMP-1 mRNA 
level and 28S rRNA was perform with total RNA extracted from HSF cultured in 
DMEM+10%FCS 72h post-transfection with 20 nM of  an irrelevant siRNA (siScr), the first 
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siRNA targeting Cdc42 (1st siCdc42) or the second siRNA targeting Cdc42 (2nd siCdc42). 
Sample to sample variations in RT-PCR efficiency is controlled by a known copy number of 
synthetic RNA co-transcribed and co-amplified with the same primers which generate a 
product of larger size (*). 
 
Fig. 6. Multiple knock-down of RhoGTPases revealed a role for Rac1, but not RhoA, in 
MMP-1 overexpression following Cdc42 silencing. HSF were transfected with the indicated 
siRNA at the concentration of 10 nM. To reach the same final concentration of 30 nM of 
siRNA in each condition, transfection mix were supplemented with siScr. Representative 
Western blot analysis of whole cell lysates 72h post-transfection (cell lysates) and of serum 
free media conditioned for 16h between day 2 and day 3 post-transfection are shown. Cell 
lysates and conditioned media (C.M.) were analysed by immunoblotting with specific 
antibodies to RhoA, Rac1, Cdc42, ERK1,2 and MMP-1. The lower panel illustrates the 
densitometric analysis of MMP-1 measurements by Western blot analysis of C.M.. Results are 
expressed as the mean+s.d. of three independent experiments. The concentrations of the 
siRNA in the table below the figures are expressed in nM. 
 
Fig. 7. MCP-1 and IL-8 overexpression following Cdc42 silencing. 
(A) Analysis of serum free media conditioned for 16h between day 2 and day 3 post-
transfection by Cytokine proteoarray. HSF were transfected with 20 nM of the siRNA 
targeting RhoA (siRhoA), Rac1 (siRac1) or Cdc42 (siCdc42), or with 20 nM of an irrelevant 
siRNA (siScr). White arrows indicate the position of the IL-8, IL-6 and MCP-1 signals 
respectively from the top to the bottom (B) Representative semi-quantitative RT-PCR analysis 
of MCP-1 and IL-8 mRNA level and 28S rRNA in total RNA extracted from HSF 72h post-
transfection with either calcium phosphate alone (CaP), an irrelevant siRNA (siScr) or with 
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the siRNA targeting RhoA (siRhoA), Rac1 (siRac1) or Cdc42 (siCdc42). The efficiency of 
the 28S RT-PCR is controlled by a known copy number of synthetic RNA co-transcribed and 
co-amplified with the same primers which generate a product of larger size (*). (C) ELISA 
measurements of MCP-1  and IL-8 in serum free media conditioned by HSF for 16h between 
day 2 and day 3 post-transfection. 
 
Fig. 8. Overexpression of MMP-1 following Cdc42 silencing is mediated through the 
ERK1,2 pathway. (A)Western blot analysis of whole cell lysates from starved HSF 72h post-
transfection with either calcium phosphate alone (CaP), 20 nM of an irrelevant siRNA (siScr) 
or with 20 nM of the siRNA targeting RhoA (siRhoA), Rac1 (siRac1) or Cdc42 (siCdc42). 
Cell lysates were analyzed by immunoblotting with specific antibodies to phospho-ERK1,2, 
phospho-p38 and to total ERK1,2 (ERK1,2). (B) Representative Western blot analysis of 
whole cell lysates of HSF 72h post-transfection (cell lysates) and of serum free media 
conditioned for 16h between day 2 and day 3 post-transfection (C.M.). HSF were transfected 
with 20 nM of an irrelevant siRNA (siScr) or with 20nM of the siRNA targeting Cdc42 
(siCdc42) and cultured between day 1 and day 3 post-transfection with the indicated 
concentrations of the MEK kinase inhibitor (U0126), of the PI3Kinase inhibitor (LY294) and 
of the p38 MAP kinase inhibitor (SB203580). Cell lysates and C.M. were analysed by 
immunoblotting with specific antibodies to Cdc42, ERK1,2 and MMP-1. 
 
Fig. 9. The ERK1,2 pathway is also required for MMP-1 overexpression following 
Cdc42 silencing with a second siRNA. (A) Representative Western blot analysis of whole 
cell lysates of HSF 72h post-transfection with calcium phosphate alone (CaP) or with the 
indicated concentrations of an irrelevant siRNA (siScr) or the second siRNA targeting Cdc42 
(2nd siCdc42). Cell lysates were analysed by immunoblotting with specific antibodies to 
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phospho-ERK1,2 and ERK1,2. (B-C) Representative Western blot analysis of serum free 
media conditioned by HSF for 16h between day 2 and day 3 post-transfection with 20 nM of 
an irrelevant siRNA (siScr), with 20nM of the siRNA targeting Cdc42 (1st siCdc42) or with 
20nM of the second siRNA targeting Cdc42 (2nd siCdc42) and cultured between day 1 and 
day 3 post-transfection with the indicated concentrations of (B) the MEK kinase inhibitor 
U0126 or (C) the p38 MAPKinase inhibitor SB203580. 
 
Fig. 10. MMP-1 overexpression following Cdc42 silencing is observed in various human 
cell lines. Representative Western blot analysis of cell lysates of human breast 
adenocarcinoma cell line HS578T, fibrosarcoma cell line HT1080 and melanoma cell line 
A2058 72h post-transfection and of serum free media conditioned by the same cells for 16h 
between day 2 and day 3 post-transfection (C.M.). Cells were transfected with 20nM of either 
an irrelevant siRNA (siScr) or the first siRNA targeting Cdc42 (siCdc42). Cell lysates and 
C.M. were analysed by immunoblotting with specific antibodies to Cdc42, ERK1,2 and 
MMP-1. 
 
Fig. 11. The rescue of Cdc42 knock-down represses the MMP-1 overexpression. 
RT-PCR analysis of Cdc42 and mutated Cdc42 (mCdc42) mRNA level and 28S rRNA was 
performed with total RNA extracted from HS578T transfected with 20 nM of either an 
irrelevant siRNA (siScr) or the first siRNA targeting Cdc42 (siCdc42) and 1µg of either 
empty pShuttle (vector) or pShuttle-mCdc42 (mCdc42). Total RNA was extracted 72h after 
transfection with the siRNA. The top left panel illustrates the amplification of mutated Cdc42 
mRNA performed with total RNA extracted from HS578T 48h after transfection with 
pShuttle-mCdc42, with (+RT) or without (-RT) the reverse transcription step. Representative 
Western blot analysis of  whole cell lysates  and of serum free media conditioned (C.M.) by 
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HS578T transfected with 20 nM of either an irrelevant siRNA (siScr) or the first siRNA 
targeting Cdc42 (siCdc42) and 1µg of either empty pShuttle (vector) or pShuttle-mCdc42 
(mCdc42) with specific antibodies to Cdc42, ERK1,2 and MMP-1. The lower panel illustrates 
the densitometric analysis of MMP-1 measurements by Western blot analysis of C.M.. Results 
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